Read the latest ideas, insights and observations on the Australian Medicinal Cannabis Industry from the team at Applied Cannabis Research
The CMOS is expected to run for five years, with patients to be recruited nationwide via medical centers, prescribing GP’s, and specialists. Earlier today the
Australia’s Largest Medicinal Cannabis Study To Date Applied Cannabis Research, Industry Heavyweights and Nationwide Medical Networks Join Forces For a Study of 20,000 Patients, Applied
Cannabidiol (CBD) basics Cannabidiol (CBD) is one of the two dominant cannabinoids in the cannabis species. Since its discovery in 1940 CBD has been subject
For medical practitioners without experience in prescribing medicinal cannabis, the complexities of prescribing CBD oil and cannabis medicines more broadly can be daunting. The sheer
Many Australians with IBD use cannabis for symptom management – but their doctors aren’t convinced Two recently published surveys on inflammatory bowel disease (IBD) and
A new survey published on June 8 2020, the Cannabis as Medicine Survey (CAMS-18), has highlighted that despite legalisation of medicinal cannabis in Australia in
Medicinal Cannabis and Wasting Syndrome: What Can It Do? Cachexia is a condition, also known as ‘wasting syndrome’, characterised by loss of body mass
The GreenFund – A new study has found that medicinal cannabis may be able to reduce the intensity of chronic pain in patients by as
STOCKHEAD MGC (ASX:MXC) will conduct a head-to-head clinical study on severe intractable epilepsy in collaboration with Cannabis Access Clinics and Epilepsy Action Australia, a direct comparison
Leave us a message
© 2020 All rights reserved, Applied Cannabis Research